Big Money’s Pro-Globus Medical Inc (NYSE:GMED) Sentiment In Q2 2018, now at 1.18

November 10, 2018 - By Rachel Eickhoff

Globus Medical, Inc. (NYSE:GMED) Corporate Logo

Globus Medical Inc’s Sentiment

In 2018 Q2 Globus Medical Inc (NYSE:GMED) big money sentiment increased to 1.18, revealed SEC filings. So its up 0.13, from 2018Q1’s 1.05. 127 funds increased and started new equity positions, while 108 cut down and sold equity positions in Globus Medical Inc so the sentiment has increased. These funds own 59.65 million shares, that’s up from 58.46 million shares in 2018Q1. Funds holding Globus Medical Inc in top 10 increased from 4 to 5 for an increase of 1. In total 29 funds closed positions, 79 reduced and 80 increased. Also 47 funds bought new Globus Medical Inc stakes.

Most Globus Medical Inc Investors

Paradigm Capital Management Inc Ny owns 735,500 shares in Globus Medical Inc as of 2018 Q2. As of 2018 Q2, 55,088 shares of Globus Medical Inc are owned by Godshalk Welsh Capital Management Inc.. In addition, Pura Vida Investments Llc reported 67,500 shares in Globus Medical Inc equivalent to 2.89% of its US equity exposure. Oak Ridge Investments Llc revealed 826,425 shares position in Globus Medical Inc. The Quebec – Canada-based fund Van Berkom & Associates Inc. holds 1.26 million shares or 1.85% of their US equity exposure.

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders.The firm is worth $5.10 billion. The firm offers products that address an array of spinal pathologies, anatomies, and surgical approaches.The P/E ratio is 38.27. It provides fusion products that are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions.

Ticker’s shares touched $51.86 during the last trading session after 9.71% change.Globus Medical, Inc. has 1.77 million shares volume, 170.21% up from normal. GMED is uptrending and has moved 72.10% since November 10, 2017. The stock outperformed the S&P 500 by 56.48%.

Thomson Horstmann And Bryant Inc holds 0.03% of its capital in Globus Medical, Inc. (NYSE:GMED) for 5,028 shs. Moreover, Kayne Anderson Rudnick Invest Ltd Co has 0.09% invested in Globus Medical, Inc. (NYSE:GMED). Panagora Asset Mgmt Inc holds 63,364 shs or 0.01% of its capital. St Johns Mgmt Ltd Liability Com reported 7,500 shs. Bahl And Gaynor invested in 37,531 shs or 0.02% of the stock. Qs reported 1,615 shs. Synovus Fincl has invested 0% in Globus Medical, Inc. (NYSE:GMED). Moreover, Wellington Mgmt Llp has 0.06% invested in Globus Medical, Inc. (NYSE:GMED) for 5.72 million shs. Credit Suisse Ag invested in 144,582 shs. Legal & General Group Pcl invested in 70,949 shs. Eagle Asset Mgmt owns 130,404 shs. Mason Street Advsrs Limited Liability Corp accumulated 37,588 shs or 0.04% of the stock. Oakbrook Investments Ltd Limited Liability Company invested in 5,600 shs. Renaissance Grp Ltd Liability reported 8,845 shs. 345 were reported by Tradewinds Cap Management Limited Liability Corporation.

Globus Medical, Inc. (NYSE:GMED) Ratings Coverage

In total 4 analysts cover Globus Medical (NYSE:GMED). “Buy” rating has 3, “Sell” are 1, while 0 are “Hold”. (NYSE:GMED) has 75% bullish analysts. 5 are the (NYSE:GMED)’s ratings reports on 10 Nov 2018 according to StockzIntelligence Inc. On Thursday, May 31 the stock of Globus Medical, Inc. (NYSE:GMED) earned “Buy” rating by Cantor Fitzgerald. On Wednesday, May 30 Leerink Swann maintained Globus Medical, Inc. (NYSE:GMED) with “Outperform” rating. The stock rating was downgraded by Bank of America to “Sell” on Wednesday, June 27. On Tuesday, September 25 the stock of Globus Medical, Inc. (NYSE:GMED) earned “Overweight” rating by Morgan Stanley. On Thursday, August 2 the firm has “Overweight” rating by Morgan Stanley given.

Another two news for Globus Medical, Inc. (NYSE:GMED) were recently published by: Seekingalpha.com on November 08, 2018 with title “Globus Medical beats by $0.07, beats on revenue”. The other Globenewswire.com‘s article was titled “Globus Medical Reports Third Quarter 2018 Results” and published on November 08, 2018.

Globus Medical, Inc. (NYSE:GMED) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.